Global Non-opioid Pain Patch Market Growth 2025-2031
Description
The global Non-opioid Pain Patch market size is predicted to grow from US$ 685 million in 2025 to US$ 803 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
United States market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patch players cover Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Pain Patch Industry Forecast” looks at past sales and reviews total world Non-opioid Pain Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patch sales for 2025 through 2031. With Non-opioid Pain Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Pain Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Segmentation by Application:
OTC
Rx
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-opioid Pain Patch market?
What factors are driving Non-opioid Pain Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patch market opportunities vary by end market size?
How does Non-opioid Pain Patch break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
United States market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patch players cover Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Pain Patch Industry Forecast” looks at past sales and reviews total world Non-opioid Pain Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patch sales for 2025 through 2031. With Non-opioid Pain Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Pain Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Segmentation by Application:
OTC
Rx
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-opioid Pain Patch market?
What factors are driving Non-opioid Pain Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patch market opportunities vary by end market size?
How does Non-opioid Pain Patch break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
128 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Non-opioid Pain Patch by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Non-opioid Pain Patch by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
